Latest filing published 28 Mar 2023 for Pharma-Bio Serv, Inc., €18k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Filings by Dov Perlysky span 4 companies, the busiest being Pharma-Bio Serv, Inc., Enzo Biochem Inc and Florham Consulting Corp. Between 25 January 2006 and 24 March 2023, the trades on record add up to 38 filings.
In open-market terms, that means 3 purchases worth €31k on one side and 1 sale worth €354k on the other. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 13 share grants and 12 option exercises.
Most recently, on 28 March 2023, the filings show a share grant worth €18k in Pharma-Bio Serv, Inc. The latest purchase dates back some time: it was published 2,924 days ago, on 22 October 2018. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 33 declarations